Dr Hector Ivan Diaz Lopez, MD in Coto Laurel, PR - Obstetrics & Gynecology

Dr Hector Ivan Diaz Lopez, MD is a Obstetrics & Gynecology physician based in Coto Laurel, Puerto Rico. Dr Hector Ivan Diaz Lopez is licensed to practice in Puerto Rico (license number 011555) and his current practice location is Torre San Cristobal, Suite 406, Coto Laurel, Puerto Rico. He can be reached at his office (for appointments etc.) via phone at (787) 840-0384.

NPI number for Dr Hector Ivan Diaz Lopez is 1578595385 and his current mailing address is Po Box 801235, Coto Laurel, Puerto Rico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578595385.

Contact Information

	Dr Hector Ivan Diaz Lopez, MD
	Torre San Cristobal, Suite 406, Coto Laurel, PR 00780
	(787) 840-0384
	(787) 840-0384

Physician's Profile

Full Name	Dr Hector Ivan Diaz Lopez
Gender	Male
Speciality	Obstetrics & Gynecology
Location	Torre San Cristobal, Coto Laurel, Puerto Rico
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578595385
Provider Enumeration Date: 07/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Hector Ivan Diaz Lopez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578595385	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	011555 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Hector Ivan Diaz Lopez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Hector Ivan Diaz Lopez, MD Po Box 801235, Coto Laurel, PR 00780-1235 Ph: (787) 840-0384	Dr Hector Ivan Diaz Lopez, MD Torre San Cristobal, Suite 406, Coto Laurel, PR 00780 Ph: (787) 840-0384

News Archive

FDA approves Taxotere for head and neck cancers

The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).

U-Systems receives positive FDA panel review for somo•v ABUS system for breast cancer screening

U-Systems, the leader in automated breast ultrasound, today announced that the U.S. Food and Drug Administration's Radiological Devices Panel of the Medical Devices Advisory Committee recommended approval of the somo•v Automated Breast Ultrasound (ABUS) system.

Morinda Holdings chosen as one of the Healthiest Companies in America

Amid the glaring spotlight on healthcare reform in the US, Interactive Health Solutions published their list of the "Healthiest Companies in America" for 2010. The list is a group of 34 companies that have significantly reduced healthcare costs through employee participation in a prevention-based health program in the workplace. Morinda Holdings, Inc. (parent company of Tahitian Noni International) was chosen from over 1,300 corporations in the United Sates ranging in size from as little as 100 to over 50,000 employees, as one of the "Healthiest Companies in America."

Study shows relationship between built environment, SES and changes in BMI

People living in neighbourhoods where they perceived traffic made it unpleasant to walk were more likely to have a higher BMI than those who didn't, according to a new University of Alberta study looking at the relationship between the built environment, socio-economic status, and changes in body mass index over a six year period.

BPA exposure during pregnancy can lead to changes in circadian rhythms

Exposure to the widely used chemical bisphenol A during pregnancy, even at levels lower than the regulated "safe" human exposure level, can lead to changes in circadian rhythms, according to a mice study to be presented Monday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La. The researchers report these changes may be a contributing factor in hyperactivity seen in BPA-exposed mice.

Dr Hector Ivan Diaz Lopez, MD - Obstetrics & Gynecology in Coto Laurel, PR